BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27090942)

  • 21. Thrombopoietin mimetics for patients with myelodysplastic syndromes.
    Dodillet H; Kreuzer KA; Monsef I; Skoetz N
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD009883. PubMed ID: 28962071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation.
    Tien HF; Tang JH; Tsay W; Liu MC; Lee FY; Wang CH; Chen YC; Shen MC
    Br J Haematol; 2001 Jan; 112(1):148-54. PubMed ID: 11167795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
    Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
    JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ageing, exposure to pollution, and interactions between climate change and local seasons as oxidant conditions predicting incident hematologic malignancy at KINSHASA University clinics, Democratic Republic of CONGO (DRC).
    Nkanga MSN; Longo-Mbenza B; Adeniyi OV; Ngwidiwo JB; Katawandja AL; Kazadi PRB; Nzonzila AN
    BMC Cancer; 2017 Aug; 17(1):559. PubMed ID: 28835214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary, between 1983 and 2012. Analysis of data from a thirty-year period].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2013 Nov; 154(47):1858-64. PubMed ID: 24240522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States.
    Shenolikar R; Durden E; Meyer N; Lenhart G; Moore K
    Gynecol Oncol; 2018 Nov; 151(2):190-195. PubMed ID: 30268525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute leukaemia and myelodysplastic syndromes with chromosomal rearrangement involving 11q23 locus, but not
    Zuo W; Wang SA; DiNardo C; Yabe M; Li S; Medeiros LJ; Tang G
    J Clin Pathol; 2017 Mar; 70(3):244-249. PubMed ID: 27496968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme.
    van der Helm LH; Alhan C; Wijermans PW; van Marwijk Kooy M; Schaafsma R; Biemond BJ; Beeker A; Hoogendoorn M; van Rees BP; de Weerdt O; Wegman J; Libourel WJ; Luykx-de Bakker SA; Minnema MC; Brouwer RE; Croon-de Boer F; Eefting M; Jie KS; van de Loosdrecht AA; Koedam J; Veeger NJ; Vellenga E; Huls G
    Br J Haematol; 2011 Dec; 155(5):599-606. PubMed ID: 21981697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of myeloid malignancies by subtype in Hong Kong and comparisons with Asian and white men and women in the United States.
    Bassig BA; Hu W; Morton LM; Ji BT; Xu J; Linet MS; Kwong YL; Rothman N; Wong KF; Lan Q
    Leuk Lymphoma; 2022 Aug; 63(8):1917-1924. PubMed ID: 35412943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incidence, risk factors, and survival of acute myeloid leukemia secondary to myelodysplastic syndrome: A population-based study.
    Ye X; Chen D; Zheng Y; Wu C; Zhu X; Huang J
    Hematol Oncol; 2019 Oct; 37(4):438-446. PubMed ID: 31378958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 mutation in the myelodysplastic syndromes.
    Adamson DJ; Dawson AA; Bennett B; King DJ; Haites NE
    Br J Haematol; 1995 Jan; 89(1):61-6. PubMed ID: 7833278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthropometric factors and risk of myeloid leukaemias and myelodysplastic syndromes: a prospective study and meta-analysis.
    Teras LR; Patel AV; Carter BD; Rees-Punia E; McCullough ML; Gapstur SM
    Br J Haematol; 2019 Jul; 186(2):243-254. PubMed ID: 30977126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes.
    Aul C; Gattermann N; Schneider W
    Br J Haematol; 1992 Oct; 82(2):358-67. PubMed ID: 1419819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
    J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence, survival and prevalence of myeloid malignancies in Europe.
    Visser O; Trama A; Maynadié M; Stiller C; Marcos-Gragera R; De Angelis R; Mallone S; Tereanu C; Allemani C; Ricardi U; Schouten HC;
    Eur J Cancer; 2012 Nov; 48(17):3257-66. PubMed ID: 22770878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
    Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
    Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS.
    Mawad R; Becker PS; Hendrie P; Scott B; Wood BL; Dean C; Sandhu V; Deeg HJ; Walter R; Wang L; Myint H; Singer JW; Estey E; Pagel JM
    Br J Haematol; 2016 Jan; 172(2):238-45. PubMed ID: 26568032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.